Computational phenotyping of obstructive airway diseases: protocol for a systematic review

Background: Over the last decade, computational sciences have contributed immensely to characterization of phenotypes of airway diseases, but it is difficult to compare derived phenotypes across studies, perhaps as a result of the different decisions that fed into these phenotyping exercises. We aim to perform a systematic review of studies using computational approaches to phenotype obstructive airway diseases in children and adults.Methods and analysis: We will search PubMed, EMBASE, Scopus, Web of Science, Google scholar for papers published between 2010 and 2020. Conferences proceedings, reference list of included papers, and experts will form additional sources of literature. Two reviewers will independently screen the retrieved studies for eligibility, extract relevant data, and perform quality appraisal of included studies. A third reviewer will arbitrate any disagreements in these processes. Quality appraisal of the studies will be undertaken using the Effective Public Health Practice Project quality assessment tool. We will use summary tables to describe the included studies. We will narratively synthesize the generated evidence, providing critical assessment of the populations, variables, and computational approaches used in deriving the phenotypes across studiesConclusion: As progress continues to be made in the area of computational phenotyping of chronic obstructive airway diseases, this systematic review, the first on this topic, will provide the state-of-the-art on the field and highlight important perspectives for future works.Registration and reporting:The full protocol for this systematic review is registered in the International Prospective Register of Systematic Reviews with the number CRD42020164898 according to the requirements of the PRISMA-P guideline(1, 2).

[1]  Tudor I. Oprea,et al.  Chronic obstructive pulmonary disease phenotypes using cluster analysis of electronic medical records , 2018, Health Informatics J..

[2]  Tina Hernandez-Boussard,et al.  Advances in Electronic Phenotyping: From Rule-Based Definitions to Machine Learning Models. , 2018, Annual review of biomedical data science.

[3]  Krishnaprasad Thirunarayan,et al.  “How Is My Child’s Asthma?” Digital Phenotype and Actionable Insights for Pediatric Asthma , 2018, JMIR pediatrics and parenting.

[4]  Anna Okula Basile,et al.  Informatics and machine learning to define the phenotype , 2018, Expert review of molecular diagnostics.

[5]  Improving the quality of the evidence – The necessity to lead by example , 2017, Journal of Clinical Neuroscience.

[6]  Jennifer G. Dy,et al.  Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts , 2017, Thorax.

[7]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation , 2016, British Medical Journal.

[8]  David Sontag,et al.  Electronic medical record phenotyping using the anchor and learn framework , 2016, J. Am. Medical Informatics Assoc..

[9]  Yan Liu,et al.  Deep Computational Phenotyping , 2015, KDD.

[10]  Y. Saeys,et al.  Phenotyping asthma, rhinitis and eczema in MeDALL population‐based birth cohorts: an allergic comorbidity cluster , 2015, Allergy.

[11]  J. Bourbeau,et al.  Derivation and validation of clinical phenotypes for COPD: a systematic review , 2015, Respiratory Research.

[12]  P. Shekelle,et al.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement , 2015, Systematic Reviews.

[13]  M. Dobbins,et al.  Tools to support evidence-informed public health decision making , 2014, BMC Public Health.

[14]  Nicolas Roche,et al.  Identification of Clinical Phenotypes Using Cluster Analyses in COPD Patients with Multiple Comorbidities , 2014, BioMed research international.

[15]  J. Pathak,et al.  Electronic health records-driven phenotyping: challenges, recent advances, and perspectives. , 2013, Journal of the American Medical Informatics Association : JAMIA.

[16]  I. Pavord,et al.  Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms? , 2013, Thorax.

[17]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[18]  D. Hamilos,et al.  Rhinitis and sinusitis. , 2010, The Journal of allergy and clinical immunology.

[19]  D. Caillaud,et al.  Clinical COPD phenotypes: a novel approach using principal component and cluster analyses , 2010, European Respiratory Journal.

[20]  M. Weatherall,et al.  Distinct clinical phenotypes of airways disease defined by cluster analysis , 2009, European Respiratory Journal.

[21]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[22]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[23]  J. Popay,et al.  Guidance on the conduct of narrative synthesis in sytematic reviews , 2006 .

[24]  Jennie Popay,et al.  Guidance on the conduct of narrative synthesis in systematic Reviews. A Product from the ESRC Methods Programme. Version 1 , 2006 .

[25]  I. Pavord,et al.  Multi‐dimensional phenotyping: towards a new taxonomy for airway disease , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[26]  P. Gergen,et al.  Healthcare expenditures for sinusitis in 1996: contributions of asthma, rhinitis, and other airway disorders. , 1999, The Journal of allergy and clinical immunology.

[27]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .